What caused the pre-market drop in MDG1.F stock?

The pre-market drop to **€0.059** reflects thin liquidity (**volume 125.00**), ongoing liquidation of Medigene AG assets, and market uncertainty over timing of any distribution. Low trading depth magnifies price moves.

What is Meyka AI’s view on MDG1.F stock?

Meyka AI rates MDG1.F **58.42/100 (C+)** with a HOLD suggestion. The model highlights balance-sheet cash but flags liquidation and low liquidity as primary risks that limit upside for most investors.

What price targets should investors watch for MDG1.F stock?

Meyka AI’s scenarios: base **€0.045** (down **-23.73%**), bull **€0.250** (+**323.73%**) and bear **€0.020** (-**66.10%**). These are model projections, not guarantees; monitor corporate announcements closely.

How liquid is MDG1.F stock on XETRA?

Liquidity is very low: **avg volume 10,257.00** vs current volume **125.00**, and relative volume **0.01**. Expect wide spreads and large price swings on small trades.

DE Stocks

MDG1.F falls 19.62% pre-market on XETRA: thin liquidity and liquidation risk in focus

ByHuzaifa Zahoor January 21, 2026January 21, 2026

MDG1.F stock opened the pre-market session on XETRA at €0.059, down 19.62% from yesterday’s close as traders priced in persistently low liquidity and the company’s ongoing liquidation process. Trading volume is thin at 125.00 shares versus a 50-day average of 10,257.00, amplifying intraday moves. Key ratios show EPS -1.21 and PE -0.05, reflecting negative earnings and a micro-cap market cap of €916,678.00. Investors should treat short-term moves cautiously given the unusual corporate status and very low share price.